Rafoxanide and Impurities
Rafoxanide
Controlled ProductCAS:22662-39-1
Formula:
C19H11Cl2I2NO3
Color and Shape:
Neat
Molecular weight:
626.01
Ref: 86-MM0363.00
| 250mg | 303.00 € |
Estimated delivery in United States, on Thursday 9 Jan 2025
Ref: 4Z-R-691
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Ref: 4Z-R-693
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Ref: 4Z-R-692
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Rafoxanide
CAS:22662-39-1
Rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancer.
Formula:
C19H11Cl2I2NO3
Purity:
99.47%
Color and Shape:
Slight Yellowish Brown Injectable Solution &White Oral Solution
Molecular weight:
626.01
Ref: TM-T7093
| 1g | 97.00 € | ||
| 500mg | 63.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Rafoxanide
CAS:22662-39-1
Applications Rafoxanide is a thyroid hormone receptor. References Bernal, J., et al.: Vitam. Horm., 71, …
Formula:
C19H11Cl2I2NO3
Color and Shape:
White
Molecular weight:
626.01
Ref: TR-R073500
| 1g | 192.00 € | ||
| 250mg | 92.00 € | ||
| 500mg | 130.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
